Pay in 4 interest-free payments of $30.50 Learn more
Ships within 48 hours · Estimated delivery Jul 25 - Jul 30
(2011) Breast Cancer Res
CAS Number: 745017-94-1
Formula: C24H19N3O6
Therapeutic potential of AZD1480 for the treatment of human glioblastoma
Conversion of human fibroblasts into functional cardiomyocytes by small molecules
ONX-0914 - Immunoproteasome Inhibitor. CAS# 960374-59-8 size:10mg solid (2011) Breast Cancer ResONX 0914, CAS No. 960374 59 8, is an immunoproteasome inhibitor. It selectively inhibits lowmolecular mass polypeptide 7 (LMP7, encoded by Psmb8), the chymotrypsin like subunit of the immunoproteasome, with an IC50 < 100 nM. It blocked presentation of LMP7 specific, MHC Irestricted antigens in vitro and in vivo with minimal cross reactivity for the constitutive proteasome. Selective inhibition of LMP7 by ONX 0914 blocked production of interleukin 23
US$ 1205.00
US$ 25.00